Points to consider for a validation study of iPS cell-derived cardiomyocytes using a multi-electrode array system-Reference-Cited by-同舟云学术

Points to consider for a validation study of iPS cell-derived cardiomyocytes using a multi-electrode array system

Published:2016-09 Issue: Volume:81 Page:196-200
ISSN:1056-8719
Container-title:Journal of Pharmacological and Toxicological Methods
language:en
Short-container-title:Journal of Pharmacological and Toxicological Methods

Author:

Kanda Yasunari,Yamazaki Daiju^ORCID,Kurokawa Junko,Inutsuka Takashi,Sekino Yuko

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference36 articles.

1. International Conference on Harmonisation; Guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice. Fed Regist 70;Anonymous,2005

2. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice. Fed Regist 70;Anonymous,2005

3. Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes;Asakura;Journal of Pharmacological and Toxicological Methods,2015

4. Production of de novo cardiomyocytes: Human pluripotent stem cell differentiation and direct reprogramming;Burridge;Cell Stem Cell,2012

5. Revolution dawning in cardiotoxicity testing;Chi;Nature Reviews Drug Discovery,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Contractile Function Using Human iPS Cell-derived Cardiomyocytes;YAKUGAKU ZASSHI;2024-03-01

2. Overview of the ICH E14/S7B: Questions and Answers;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

3. The evolving role of investigative toxicology in the pharmaceutical industry;Nature Reviews Drug Discovery;2023-02-13

4. Long-term in vitro recording of cardiac action potentials on microelectrode arrays for chronic cardiotoxicity assessment;Archives of Toxicology;2023-01-06

5. Toward Regulatory Acceptance of MPS—Cardiac Safety Assessment as an Example—;YAKUGAKU ZASSHI;2023-01-01